Tris(4-bromophenyl)phosphane

Catalog No.: 
ACILOK534
CAS No.: 
29949-81-3
Molecular Formula: 
C18H12Br3P
Molecular Weight: 
498.98
Tris(4-bromophenyl)phosphane structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g95%$160.00In stockIn stock
25g95%$590.00In stockIn stock
100g95%$1888.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameTris(4-bromophenyl)phosphane
IUPAC Nametris(4-bromophenyl)phosphane
MDL No.MFCD02690473
Molecular FormulaC18H12Br3P
Molecular Weight498.98
SMILESBrC1=CC=C(P(C2=CC=C(Br)C=C2)C3=CC=C(Br)C=C3)C=C1
InChI KeyGMRACXJRJFIBHU-UHFFFAOYSA-N
Synonymtris-para-bromophenylphosphane;Phosphine, tris(4-bromophenyl)-;Tris(4-bromophenyl)phosphane;ris-para-bromophenylphosphane
CAS No.29949-81-3
PubChem CID4244444

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACILOK534 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKXSD380 route compound structure diagram
    ACKXSD380589-87-7In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACILOK534 route product structure diagram
    ACILOK53429949-81-3In Stock
Inquiry

2. ACILOK534 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACILOK534 route product structure diagram
    ACILOK53429949-81-3In Stock
Inquiry

3. ACILOK534 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACILOK534 route product structure diagram
    ACILOK53429949-81-3In Stock
Inquiry

Comments (0)